REQUEST A DEMO
Total
USD $0.00
Search more companies

Genject Saglik Urunleri Ve Kimya A.S. (Turkiye)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Genject Saglik Urunleri Ve Kimya Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Genject Saglik Urunleri Ve Kimya A.S. is an enterprise located in Turkiye, with the main office in Ankara. The enterprise operates in the Surgical and Medical Instrument Manufacturing industry. It was established on May 24, 2010. It currently has a total number of 80 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 222.65% in 2022. Its total assets grew by 79.67% over the same period.

Headquarters
No:24-1 Alci Osb Mahallesi 2013 Caddesi Sincan
Ankara; Central Anatolia; Postal Code: 06930

Contact Details: Purchase the Genject Saglik Urunleri Ve Kimya A.S. report to view the information.

Website: http://www.genject.com

Basic Information
Total Employees:
Purchase the Genject Saglik Urunleri Ve Kimya A.S. report to view the information.
Outstanding Shares:
Purchase the Genject Saglik Urunleri Ve Kimya A.S. report to view the information.
Incorporation Date:
May 24, 2010
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Genject Saglik Urunleri Ve Kimya A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
222.65%
Total operating revenue
222.65%
Operating profit (EBIT)
840.51%
Net Profit (Loss) for the Period
N/A
Total assets
79.67%
Total equity
69.67%
Operating Profit Margin (ROS)
18.22%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-5.34%
Quick Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?